Novo Nordisk 3. Juni 2026 Novo Nordisk Trial Updates Test Support For Obesity And Diabetes Valuation - simplywall.st
FierceBiotech 3. Juni 2026 Ascidian, Lilly ink RNA exon editing pact worth up to $1.9B for genetic kidney diseases
Boston Scientific 3. Juni 2026 Boston Scientific to build distribution facility in Plainfield - Fox 59
Endpoints News 3. Juni 2026 Lilly strikes Ascidian deal worth up to $1.9B for RNA editing in kidney diseases
Cell 3. Juni 2026 Plant cell wall-plasma membrane attachments mediate stress resilience through cellulose synthase complexes and remorins
Cell 3. Juni 2026 Explosive cytotoxicity of ruptoblasts bridges hormone surveillance and immune defense
Roche Media 3. Juni 2026 Roche’s giredestrant secures FDA priority review for breast cancer - Pharmaceutical Technology
Pfizer 3. Juni 2026 Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 - The Motley Fool
Novo Nordisk 3. Juni 2026 Novo Nordisk rolls out Wegovy pill in the UAE — testing appetite outside the U.S. with first global launch - CNBC
Pfizer 3. Juni 2026 Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 - Yahoo Finance
Insilico Medicine 3. Juni 2026 Insilico Medicine Appoints Jue Wang, PhD as Global Head of Business Development - Insilico Medicine
BioNTech 3. Juni 2026 Opportunities in the Oncology Market: Positioning for the Next Billion-Dollar Catalyst with BioNTech, Vidac Pharma, and Pfizer - news.financial
Thermo Fisher 3. Juni 2026 Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate Drug Discovery - BioSpectrum Asia
eLife 3. Juni 2026 HSD17B7 is required for the function of sensory hair cells by regulating cholesterol synthesis